Crossmark

Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)

Crossref DOI link: https://doi.org/10.1038/s43856-025-01195-w

Published Online: 2025-11-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Qianqian

Zhu, Yixuan

Gao, Jingli

Ni, Wenjing

Liu, Shanghao

Rui, Fajuan

Bai, Xue

Geng, Nan

Jin, Rui

Sun, Yuxiang

Chen, Yijie

Fan, Zhiwen

Wu, Chao

Qi, Xiaolong https://orcid.org/0000-0002-3559-5855
Shi, Junping https://orcid.org/0000-0001-9434-897X
Li, Jie https://orcid.org/0000-0003-0973-8645
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82170609)

National Natural Science Foundation of China (81970545)

Natural Science Foundation of Jiangsu Province (BK20231118)
License Information

Text and Data Mining valid from 2025-11-21

Version of Record valid from 2025-11-21
More Information

Article History

Received: 6 March 2025

Accepted: 29 September 2025

First Online: 21 November 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below